Clinical Trial Alert

Nephrology Times:
doi: 10.1097/01.NEP.0000415396.87326.e9
Clinical Trial Alert

    The following is a partial list of new clinical trials recently added to the National Institutes of Health's ClinicalTrials.gov online registry. More information on these trials is available at www.clinicaltrials.gov.

    Back to Top | Article Outline

    • Acute Kidney Injury •

    NCT01560650

    Effect of the Intensity of Continuous Renal Replacement Therapy in Patients with Acute Kidney Injury

    Ages eligible for study: 18 years and older

    Sponsors and collaborators: Wei Shi, Guangdong General Hospital

    Contact: Wei Shi, MD, PhD

    Phone: 86-20-83850849

    E-mail: weishi_gz@126.com

    NCT01557361

    Standard Versus Accelerated Initiation of Dialysis in Acute Kidney Injury (STARRT–AKI)

    Ages eligible for study: 18 years and older

    Sponsors and collaborators: St. Michael's Hospital, Toronto; Canadian Institutes of Health Research; Alere San Diego

    Contact: Karen L. Pope, MSc

    Phone: 416-864-6060, ext. 7853

    E-mail: popek@smh.ca

    Contact: Judith Hall, MSc

    Phone: 416-864-6060, ext. 7121

    E-mail: hallju@smh.ca

    NCT01573104

    Evaluating Novel Biomarkers in Acute Kidney Injury

    Ages eligible for study: 18 years to 90 years

    Sponsors and collaborators: Dr. Robert Docking, University of Glasgow

    Contact: Robert I. Docking, MBChB

    Phone: 447717824350

    E-mail: robert.iain.docking@gmail.com

    Contact: John Kinsella, MD

    Phone: 4411412114625

    E-mail: john.kinsella@glasgow.ac.uk

    NCT01573962

    A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury

    Ages eligible for study: 21 years and older

    Sponsors and collaborators: Astute Medical

    Contact: Karin Hughes, PhD

    Phone: 858-882-0466

    E-mail: khughes@astutemedical.com

    NCT01582360

    Pharmacokinetics of Anti-infectives/Antibiotics in Critically Ill Patients in Need of Continuous Renal Replacement Therapy

    Ages eligible for study: 18 years and older

    Sponsors and collaborators: Oslo University Hospital

    Contact: Elin Helset, MD, PhD

    Phone: +4722119585

    E-mail: ehj@ous-hf.no

    Back to Top | Article Outline

    • Anemia •

    NCT01587924

    Four-Week Switch Study in Hemodialysis-Dependent Subjects with Anemia Associated with Chronic Kidney Disease

    Ages eligible for study: 18 years and older

    Sponsors and collaborators: GlaxoSmithKline, Pharmaceutical Product Development Clinical Research Organization

    Contact: US GSK Clinical Trials Call Center

    Phone: 877-379-3718

    E-mail: GSKClinicalSupportHD@gsk.com

    NCT01587898

    Four-Week Correction Study in Subjects with Anemia Associated with Chronic Kidney Disease Who Are Not Undergoing Dialysis

    Ages eligible for study: 18 years and older

    Sponsors and collaborators: GlaxoSmithKline, Pharmaceutical Product Development Clinical Research Organization

    Contact: US GSK Clinical Trials Call Center

    Phone: 877-379-3718

    E-mail: GSKClinicalSupportHD@gsk.com

    NCT01581073

    Prevention of End-Stage Kidney Disease by Darbepoetin Alfa in Chronic Kidney Disease Patients with Nondiabetic Kidney Disease (PREDICT)

    Ages eligible for study: 20 years to 85 years

    Sponsors and collaborators: Translational Research Informatics Center, Kobe, Hyogo, Japan; Showa University School of Medicine

    Contact: Enyu Imai, MD, PhD

    Phone: +81-52-744-2192

    E-mail: imai@med.nagoya-u.ac.jp

    Back to Top | Article Outline

    • Chronic Kidney Disease–Mineral and Bone Disorder •

    NCT01561222

    Effect of Vitamin D Supplement on Osteoprotegin Expression and Disease Progression in Patients with Chronic Kidney Disease Stage 1 and 2

    Ages eligible for study: 18 years to 80 years

    Sponsors and collaborators: Taixing People's Hospital

    Contact: Xu Zhang

    Phone: 008-613-905-266-789

    E-mail: dr.zhangxu@tom.com

    Contact: Cai-xia Zhao

    Phone: 008-615-896-079-628

    E-mail: zhaocaixia2010@yahoo.cn

    NCT01574326

    An Efficacy and Safety Study of Sevelamer Carbonate in Hyperphosphatemic Pediatric Patients with Chronic Kidney Disease

    Ages eligible for study: 18 years and younger

    Sponsors and collaborators: Genzyme

    Contact: Medical Information

    Phone: 800-745-4447

    E-mail: medinfo@genzyme.com

    NCT01554982

    A Long-Term Safety Extension Trial of Ferric Citrate in Patients with End-Stage Renal Disease (ESRD) on Dialysis

    Ages eligible for study: 18 years and older

    Sponsors and collaborators: Keryx Biopharmaceuticals

    Contact: Mohammed Sika, PhD

    E-mail: mohammed.sika@vanderbilt.edu

    Back to Top | Article Outline

    • Contrast-Induced Acute Kidney Injury •

    NCT01562925

    Effect of Red Wine, White Wine, and Beer on Contrast Medium-Induced Acute Kidney Injury (RenPro-II-WINE)

    Ages eligible for study: 18 years and older

    Sponsors and collaborators: University of Cologne

    Contact: Fikret Er, MD

    Phone: +4922147832544

    E-mail: fikret.er@uk-koeln.de

    Contact: Natig Gassanov, MD

    Phone: +4922147832354

    E-mail: natig.gassanov@uk-koeln.de

    Back to Top | Article Outline

    • End-Stage Renal Disease •

    NCT01562340

    Pomegranate and Hemodialysis Pilot Trial (POM Pilot)

    Ages eligible for study: 18 years to 85 years

    Sponsors and collaborators: University of Washington

    Contact: Lori Linke

    Phone: 206-616-8574

    E-mail: lori.linke@nwkidney.org

    Contact: John Kundzins

    Phone: 206-616-8574

    E-mail: info@kri.washington.edu

    NCT01561118

    DiaSport: Endurance-Orientated Training Program with Children and Adolescents on Maintenance Hemodialysis

    Ages eligible for study: 6 years to 19 years

    Sponsors and collaborators: University of Cologne, German Sport University Cologne, Hannover Medical School

    Contact: Bernd Hoppe, MD

    Phone: +49-221-478, ext. 6831

    E-mail: bernd.hoppe@uk-koeln.de

    Contact: Markus Feldkötter, MD

    Phone: +49-221-478, ext. 6831

    E-mail: markus.feldkoetter@uk-koeln.de

    Back to Top | Article Outline

    • Hypertension •

    NCT01560312

    Renal Denervation in Refractory Hypertension (PRAGUE-15)

    Ages eligible for study: 18 years and older

    Sponsors and collaborators: Charles University, Czech Republic; University Hospital Olomouc; Cardiocenter Podlesí, Trinec, Czech Republic

    Contact: Petr Widimsky, MD

    Phone: 00420267163159

    E-mail: petr.widimsky@fnkv.cz

    NCT01549444

    Renin and Aldosterone Levels in the Preterm Neonate at Risk for Hypertension

    Ages eligible for study: 26 weeks to 34 weeks

    Sponsors and collaborators: Ottawa Hospital Research Institute, Physicians' Services Incorporated Foundation

    Contact: Erika Bariciak, MD

    Phone: 613-737-7600, ext. 2954

    E-mail: bariciak@cheo.on.ca

    Contact: Brigitte Lemyre, MD

    Phone: 613-737-8899, ext. 71882

    E-mail: blemyre@ottawahospital.on.ca

    © 2012 Lippincott Williams & Wilkins, Inc.